Apollo Medical results, guidance, call

 Financial Highlights for the Year Ended December 31, 2022:

• Total revenue of $1.14 billion, an increase of 48% from $773.9 million for the prior year

• Net income attributable to ApolloMed of $49.0 million

• Earnings per share - diluted ("EPS – diluted") of $1.08

• Adjusted EBITDA of $140.0 million, an increase of 5%, compared to $133.5 million for the prior year, resulting in an Adjusted EBITDA margin of 12.2%(1)

• Cash and cash equivalents of $288.0 million at December 31, 2022

Guidance:

ApolloMed is providing the following guidance for total revenue, net income, EBITDA, Adjusted EBITDA, and EPS - diluted. The net income and EBITDA guidance ranges below include the impact of the excluded assets held by Allied Physicians of California, a Professional Medical Corporation's ("APC"), which are solely for the benefit of APC and its shareholders. Any gains or losses associated with these excluded assets do not have an impact on Adjusted EBITDA and EPS - diluted. These guidance assumptions are based on the Company's existing business, current view of existing market conditions and assumptions for the year ending December 31, 2023.

($ in millions)	2023 Guidance Range
	Low		High
Total revenue	$              1,300.0		$              1,500.0
Net income	$                   49.5		$                   71.5
EBITDA	$                   89.5		$                 129.5
Adjusted EBITDA	$                 120.0		$                 160.0
EPS – diluted	$                   0.95		$                   1.20

Conference Call and Webcast Information:

ApolloMed will host a conference call at 5:30 a.m. PT/8:30 a.m. ET today (Friday, February 24, 2023), during which management will discuss the results of the fourth quarter and year ended December 31, 2022. To participate in the conference call, please use the following dial-in numbers about 5 minutes prior to the scheduled conference call time:

U.S. & Canada (Toll-Free):		(877) 407-9753
International (Toll):		(201) 493-6739

The conference call can also be accessed at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0Kd2PA99.

An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://www.apollomed.net/investors/news-events/ir-calendar) after issuance of the earnings release and will be filed as an exhibit to ApolloMed's current report on Form 8-K to be filed with the SEC, accessible at www.sec.gov.

Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

https://finance.yahoo.com/news/apollo-medical-holdings-inc-reports-213500834.html